कृपया अन्य खोज का प्रयास करें
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Kabir Nath | 58 | 2022 | CEO & Director |
David York Norton | 73 | 2018 | Independent Chairman & Lead Independent Director |
Thomas Lonngren | 74 | 2018 | Independent Non-Executive Director |
Annalisa Mary Jenkins | 59 | 2018 | Independent Non-Executive Director |
Linda R. McGoldrick | 69 | 2020 | Independent Non Executive Director |
Kirk Rutter | - | - | Special Advisor of Patient Experience |
Daphne Karydas | 51 | 2023 | Independent Director |
Alan F. Schatzberg | 79 | - | Member of Scientific Advisory Network |
Paul Summergrad | - | - | Member of Scientific Advisory Network |
Thomas R. Insel | 71 | - | Member of Scientific Advisory Network |
Diego Pizzagalli | - | - | Member of Scientific Advisory Network |
Robert D. McQuade | 67 | 2020 | Independent Non Executive Director |
Gul Dolen | - | - | Member of Scientific Advisory Network |
John Rush | - | - | Member of Scientific Advisory Network |
Wayne Joseph Riley | 65 | 2021 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है